Announcements
November 8, 2018

The Biggest Problems

Some problems in life are simple — you’re tired, so you should go to sleep. Your car engine revs when you push the gas, so you should shift into a different gear.

Some are a little more complex. Doing a household budget, or treating a patient’s aches or pains.

Then, on a totally different scale, you’ve got those big, horrible problems that make waves in whole societies.

Regenstrief is proud to be launching The Problem, a podcast that will examine how professionals of all stripes are doing their part to confront society’s biggest issues. Each season will focus on a different big problem. Inside that season, each episode will talk about how professionals in different disciplines or social institutions are doing their part to solve the season’s problem.

Our first season, starting today, will focus on the opioid crisis. For the last few years, the country has been devastated by addiction. Overdose deaths continue to rise. In the Midwest, overdoses increased 70% between 2016 and 2017. Luckily, professionals from many backgrounds have been doing their part to stem the damage.

This season, we’ll look at how professionals in health communications, psychiatry, health systems and other disciplines have responded to the ongoing opioid crisis in Indiana. We’ll see what each field’s unique point of view brings to the table, and how they strategize to solve addiction and dependence in Indiana.

There’s so much work being done here in Indiana to move the needle on opioid dependence, and you won’t want to miss as we dive into how a variety of different disciplines are doing their part to solve the problem.

Related News

Rachel Patzer (center) and other members of the ASN panel

Regenstrief president participates in media panel with national experts

Regenstrief Institute President and CEO Rachel Patzer, PhD, MPH, joined other national experts on Thursday, October 24 on a panel

Dr. Babar Khan on All IN

Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial

Published in the journal Lancet Respiratory Medicine. Here is a link to the article. Regenstrief Institute authors: Babar Khan

Sarah Wiehe, MD

Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement

Published in the journal JAMA. Here is a link to the article. Regenstrief Institute authors: Sarah Wiehe M.D., MPH

Jiang Bian named to data science leadership positions for Regenstrief Institute, Indiana University, IU Health

INDIANAPOLIS – Jiang Bian, PhD, a highly respected, nationally recognized artificial intelligence expert and data scientist, has been named